COMPANY PROFILE

Forma Therapeutics

Explore full profile

Improving the lives of people with diabetes and other chronic conditions

Watertown, United StatesFounded 2007Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2022

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing transformative medicines for patients with rare hematologic diseases and cancers. The company operates in the biopharmaceutical sector, focusing on innovative drug discovery and development. Forma Therapeutics serves patients, healthcare providers, and the broader medical community by addressing unmet medical needs with novel therapeutic solutions. The business model revolves around research and development, clinical trials, and eventual commercialization of its drug candidates. Revenue is primarily generated through partnerships, licensing agreements, and future product sales. Forma Therapeutics emphasizes patient-centric approaches, integrating patient and community insights into their scientific endeavors to ensure impactful outcomes.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2007
Headquarters: Watertown, United States
Employees: 182
Open positions: None listed
Dealroom signal: 66.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Genetics and genomics, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Sep 2022	$1.1B	$1.1B	Novo Nordisk	↗
IPOOther financing	Jun 2020	$0	—	Undisclosed	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	Margin
2026
2025
2024
2023
2022
2021		—
2020	—	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Forma Therapeutics website traffic

Latest recorded traffic for Forma Therapeutics is 90 monthly website visits, down 80% over the last three months. Forma Therapeutics's team declined 9.9% over the past year.

Latest monthly visits90 3-month web change-80% 1-year team growth-9.9%

Monthly website visitsApr 2016–Sep 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational	11	$3.4M	$7M
FEFemtogenixDNA-interactive payloads for antibody-drug conjugates	St Albans, United Kingdom	Operational
ETEpics TherapeuticsDrug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development	Charleroi, Belgium	Operational
IPIndex PharmaceuticalsDeveloping drugs to treat inflammatory bowel disease that can help patients return to a normal life	Solna kommun, Sweden	Operational
PGPhase GenomicsPhase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes	Seattle, United States	Operational
PIPierianDxEnables clinical labs to deliver patient-specific diagnosis and treatments	St. Louis, United States	Acquired
CICirinaAt Cirina we are pioneering products that detect cancer at its earliest stages and empower you to take action	New York City, United States	Operational
TBToma BiosciencesDna-based cancer testing technology the company was incorporated in 2011 and is based in	Foster City, United States	Operational